跳至主要内容
临床试验/ITMCTR2000003617
ITMCTR2000003617尚未招募1 期

A multicenter randomized controlled clinical study of Chuanhuang prescription combined with reduced glutathione regimen in the treatment of patients with 1-2 grade AKI on the basis of 2-4 stage CKD and its clinical evaluation of early diagnostic markers

Shanghai Municipal Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • 1. It meets the diagnostic criteria of stage CKD2-4 and stage 1-2 of acute kidney injury;
  • 2. Meet the criteria for TCM syndrome diagnosis of deficiency of spleen and kidney and mutual knot of toxin and blood stasis;
  • 3. 24 hU - pro 2.5 grams or less;
  • 4. Aged between 18 and 75;
  • 5. Patients who voluntarily participate in this clinical trial and sign the informed consent.

排除标准

  • 1. pregnancy or preparation for pregnancy and breast-feeding women;
  • 2. complicated with serious primary diseases with other organs in urgent need of immediate treatment, or with malignant tumors, active tuberculosis and other consumption system diseases;
  • 3. after renal transplantation;
  • 4. mentally ill, unable to cooperate;
  • 5. allergic to therapeutic drugs;
  • 6. participants in other drug clinical trials or in other clinical trials within 3 months.

研究者

相似试验